{"id":"W4281748547","doi":"10.5489/cuaj.7846","title":"Disparity in public funding of systemic therapy for metastatic renal cell carcinoma within Canada","year":2022,"lang":"en","type":"article","venue":"Canadian Urological Association Journal","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre; University of British Columbia","funders":"","keywords":"Pazopanib; Medicine; Sunitinib; Formulary; Temsirolimus; Ipilimumab; Cabozantinib; Family medicine; Lenvatinib; Sorafenib; Expanded access; Renal cell carcinoma; Cancer; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001873598,0.0001626056,0.0003300998,0.002404592,0.002086089,0.002282472,0.0008877491,0.0004214945,0.004139574],"category_scores_gemma":[0.0125794,0.0002278134,0.0005163003,0.006630853,0.0009331409,0.000569597,0.001240753,0.0007736001,0.0001915933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08424448,"about_ca_system_score_gemma":0.1388403,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9920399,"about_ca_topic_score_gemma":0.9933609,"domain_scores_codex":[0.9948552,0.0003713051,0.000361903,0.0004736403,0.002122658,0.001815328],"domain_scores_gemma":[0.9811289,0.002243667,0.004268054,0.000436977,0.007431808,0.004490479],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003927254,0.00006265642,0.8723193,0.0005054145,0.0002584936,0.0005765817,0.003323202,0.001985418,0.0007620514,0.01242088,0.03295806,0.0744352],"study_design_scores_gemma":[0.00003595115,0.00003489147,0.9596177,0.0003405147,0.00008955938,0.0003482666,0.002476513,0.001272195,0.0003456108,0.0004717771,0.03492079,0.00004621161],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8671055,0.01036754,0.001177684,0.02814907,0.0001988609,0.0002165853,0.02987047,0.0001688205,0.06274541],"genre_scores_gemma":[0.9924111,0.001974593,0.0003828573,0.000951815,0.0000267938,0.00002496538,0.002226506,0.00001935383,0.001982133],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08424448,"threshold_uncertainty_score":0.6112394,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03799575857808152,"score_gpt":0.2341645631720607,"score_spread":0.1961688045939791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}